▶ 調査レポート

北米の動物用調剤薬品市場

• 英文タイトル:North America Market Study on Vet Compounding Pharmacies: Increased Preference for Customized Medication Accelerating Market Growth

Persistence Market Researchが調査・発行した産業分析レポートです。北米の動物用調剤薬品市場 / North America Market Study on Vet Compounding Pharmacies: Increased Preference for Customized Medication Accelerating Market Growth / MRC2202A017資料のイメージです。• レポートコード:MRC2202A017
• 出版社/出版日:Persistence Market Research / 2021年12月9日
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Site Licence¥1,124,800 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,568,800 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、北米の動物用調剤薬品市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、新型コロナウイルス感染症の危機分析、主要成功要因、製品別分析、処方別分析、動物種類別分析、国家別分析、競争分析、仮定、調査手法など、以下の構成でまとめております。

North America Vet Compounding Pharmacies Market – Scope of Report
The latest publication by Persistence Market Research on the North America vet compounding pharmacies market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for North America Vet Compounding Pharmacies market and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the North America vet compounding pharmacies market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the North America vet compounding pharmacies market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the North America vet compounding pharmacies market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the North America vet compounding pharmacies market offers information divided into four important segments – product, formulation, animal type, and country. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
CNS Agents
Anti-Infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others

Formulation
Oral
Injectables
Others

Animal Type
Companion Animals
Dogs
Cats
Equine
Others
Livestock Animals

Country
U.S.
Canada

Key Questions Answered in Report

Which countries will continue to remain the most profitable markets for vet compounding pharmacies in North America over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in North America?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the North America vet compounding pharmacies industry avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the North America vet compounding pharmacies market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the North America vet compounding pharmacies market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. North America Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Method Innovation / Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. North America GDP Growth Outlook

4.1.2. North America Healthcare Expenditure Outlook

4.1.3. Parent Market Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Availability of Alternative Dosage

4.2.2. Frequent Dispensing of CNS Drugs As Extemporaneous Medications

4.2.3. Intermittent Drug Shortages

4.2.4. Commercial Unavailability of FDA-Approved Drug Products

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Trends

4.3.4. Opportunity Analysis

5. COVID19 Crisis Analysis

5.1. Current COVID19 Probable Future Impact

5.2. Current GDP Projection and Probable Impact

5.3. COVID19 and Impact Analysis

5.3.1. Revenue by Product

5.3.2. Revenue by Formulation

5.3.3. Revenue by Animal Type

5.3.4. Revenue By Country

5.4. 2020 Market Scenario

5.5. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Key Success Factors

6.1. Treatment Adoption Analysis

6.2. Animal Healthcare Spending

6.3. Regulatory Scenario

6.4. 503A and 503B Pharmacy Comparative Analysis

7. North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

7.2. Current and Future Market Value (In US$ Mn) Projections, 2021-2031

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, By Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (In US$ Mn) Trend By Product, 2016-2020

8.3. Current and Future Market Size (In US$ Mn) Trend Analysis and Forecast By Product, 2021-2031

8.3.1. CNS Agents

8.3.2. Anti-Infective Agents

8.3.3. Hormones and Substitutes

8.3.4. Anti-inflammatory Agents

8.3.5. Others

8.4. Market Attractiveness Analysis By Product

9. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, By Formulation

9.1. Introduction / Key Findings

9.2. Historical Market Size (In US$ Mn) Trend By Formulation, 2016-2020

9.3. Current and Future Market Size (In US$ Mn) Trend Analysis and Forecast By Formulation, 2021-2031

9.3.1. Oral

9.3.2. Injectable

9.3.3. Others

9.4. Market Attractiveness Analysis By Formulation

10. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, By Animal Type

10.1. Introduction / Key Findings

10.2. Historical Market Size (In US$ Mn) Trend By Animal Type, 2016-2020

10.3. Current and Future Market Size (In US$ Mn) Trend Analysis and Forecast By Animal Type , 2021-2031

10.3.1. Companion Animals

10.3.1.1.1. Dogs

10.3.1.1.2. Cats

10.3.1.1.3. Equine

10.3.1.1.4. Others

10.3.2. Livestock Animals

10.4. Market Attractiveness Analysis By Animal Type

11. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Country

11.1. Introduction

11.2. Historical Market Size (In US$ Mn) Analysis By Country, 2016 – 2020

11.3. Current Market Size (In US$ Mn) Analysis and Forecast By Country, 2021 – 2031

11.3.1. U.S.

11.3.2. Canada

11.4. Market Attractiveness Analysis By Country

12. U.S. Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

12.1. Introduction

12.2. Historical Market Size (In US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

12.3. Current and Future Market Size (In US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2021-2031

12.3.1. By Product

12.3.2. By Formulation

12.3.3. By Animal Type

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Canada Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

13.1. Introduction

13.2. Historical Market Size (In US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020

13.3. Current and Future Market Size (In US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2021-2031

13.3.1. By Product

13.3.2. By Formulation

13.3.3. By Animal Type

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Competition Analysis

14.1. Competition Dashboard

14.2. Competition Benchmarking

14.3. Competition Deep Dive

14.3.1. Hoye’s Pharmacy

14.3.1.1. Business O

14.3.1.2. Product Portfolio

14.3.1.3. Strategy Overview

14.3.1.3.1. Marketing Strategy

14.3.1.3.2. Product Strategy

14.3.1.3.3. Channel Strategy

14.3.2. Vertisis Custom Pharmacy

14.3.2.1. Business O

14.3.2.2. Product Portfolio

14.3.2.3. Strategy Overview

14.3.2.3.1. Marketing Strategy

14.3.2.3.2. Product Strategy

14.3.2.3.3. Channel Strategy

14.3.3. Smith Caldwell Drug Store

14.3.3.1. Business O

14.3.3.2. Product Portfolio

14.3.3.3. Strategy Overview

14.3.3.3.1. Marketing Strategy

14.3.3.3.2. Product Strategy

14.3.3.3.3. Channel Strategy

14.3.4. Sixth Avenue Medical Pharmacy

14.3.4.1. Business O

14.3.4.2. Product Portfolio

14.3.4.3. Strategy Overview

14.3.4.3.1. Marketing Strategy

14.3.4.3.2. Product Strategy

14.3.4.3.3. Channel Strategy

14.3.5. Dougherty’s Pharmacy

14.3.5.1. Business O

14.3.5.2. Product Portfolio

14.3.5.3. Strategy Overview

14.3.5.3.1. Marketing Strategy

14.3.5.3.2. Product Strategy

14.3.5.3.3. Channel Strategy

14.3.6. Triangle Compounding Pharmacy Inc.

14.3.6.1. Business O

14.3.6.2. Product Portfolio

14.3.6.3. Strategy Overview

14.3.6.3.1. Marketing Strategy

14.3.6.3.2. Product Strategy

14.3.6.3.3. Channel Strategy

14.3.7. Medisca Inc.

14.3.7.1. Business O

14.3.7.2. Product Portfolio

14.3.7.3. Strategy Overview

14.3.7.3.1. Marketing Strategy

14.3.7.3.2. Product Strategy

14.3.7.3.3. Channel Strategy

14.3.8. Wedgewood Pharmacy

14.3.8.1. Business O

14.3.8.2. Product Portfolio

14.3.8.3. Strategy Overview

14.3.8.3.1. Marketing Strategy

14.3.8.3.2. Product Strategy

14.3.8.3.3. Channel Strategy

14.3.9. Millers Pharmacy

14.3.9.1. Business O

14.3.9.2. Product Portfolio

14.3.9.3. Strategy Overview

14.3.9.3.1. Marketing Strategy

14.3.9.3.2. Product Strategy

14.3.9.3.3. Channel Strategy

14.3.10. Chiron Compounding Pharmacy

14.3.10.1. Business O

14.3.10.2. Product Portfolio

14.3.10.3. Strategy Overview

14.3.10.3.1. Marketing Strategy

14.3.10.3.2. Product Strategy

14.3.10.3.3. Channel Strategy

14.3.11. MEDS Canadian Compounding Pharmacy

14.3.11.1. Business O

14.3.11.2. Product Portfolio

14.3.11.3. Strategy Overview

14.3.11.3.1. Marketing Strategy

14.3.11.3.2. Product Strategy

14.3.11.3.3. Channel Strategy

14.3.12. Aurora Compounding

14.3.12.1. Business O

14.3.12.2. Product Portfolio

14.3.12.3. Strategy Overview

14.3.12.3.1. Marketing Strategy

14.3.12.3.2. Product Strategy

14.3.12.3.3. Channel Strategy

14.3.13. Pace Pharmacy

14.3.13.1. Business O

14.3.13.2. Product Portfolio

14.3.13.3. Strategy Overview

14.3.13.3.1. Marketing Strategy

14.3.13.3.2. Product Strategy

14.3.13.3.3. Channel Strategy

14.3.14. Victoria Compounding Pharmacy

14.3.14.1. Business O

14.3.14.2. Product Portfolio

14.3.14.3. Strategy Overview

14.3.14.3.1. Marketing Strategy

14.3.14.3.2. Product Strategy

14.3.14.3.3. Channel Strategy

14.3.15. Pratt’s Compounding Pharmacy

14.3.15.1. Business O

14.3.15.2. Product Portfolio

14.3.15.3. Strategy Overview

14.3.15.3.1. Marketing Strategy

14.3.15.3.2. Product Strategy

14.3.15.3.3. Channel Strategy

14.3.16. People’s Choice Pharmacy

14.3.16.1. Business O

14.3.16.2. Product Portfolio

14.3.16.3. Strategy Overview

14.3.16.3.1. Marketing Strategy

14.3.16.3.2. Product Strategy

14.3.16.3.3. Channel Strategy

15. Assumptions and Acronyms Used

16. Research Methodology

Table 01: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Product

Table 02: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Animal Type

Table 03: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Formulation

Table 04: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 05: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021- 2031, By Product

Table 06: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021- 2031, By Animal Type

Table 07: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021- 2031, By Formulation

Table 08: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021-2031, By Product

Table 09: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021-2031, By Animal Type

Table 10: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021-2031, By Formulation